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Abstract: Emerging research from epidemiologic studies and clinical trials is demonstrating that tree nuts promote 
satiety and weight maintenance. Moreover, tree nuts contain a plethora of nutrients, natural phenolic antioxidants, and 
other bioactive compounds (e.g., phytosterols), which are now being recognized for bestowing health benefits. As will be 
discussed in this review, tree nuts have been linked to improving heart health, lowering low-density lipoprotein 
cholesterol levels, and reducing inflammation. The strongest evidence that tree nuts are cardio-protective foodstuffs 
comes from epidemiological observations indicating a consistent and well-defined inverse association between the 
frequency of nut consumption and development of coronary heart disease, and several short-term clinical trials 
demonstrating the beneficial effects of nut intake on lipid profiles as well as other intermediate markers of heart disease. 
In this review research findings from the existing literature published within the last 15 years have been compiled and 
summarised. Three bases: SCOPUS, Web Science, and PubMed were used for search. 
Keywords: Tree nuts, Fatty acids, Phytosterols, Phenolic compounds, Cardiovascular disease. 
INTRODUCTION 
Cardiovascular disease is a public health problem 
worldwide with high costs for the management of 
patients who suffer, so that any strategy for prevention, 
such as eating foods such as nuts, could be relevant to 
improving the quality of life of those suffering from 
these pathologies. 
In human nutrition tree nuts are a rich source of 
healthful lipids, plant protein, minerals, and vitamins, 
and bioactive phytocompounds. The combination of 
these beneficial nutrients is most likely responsible for 
their proposed health benefits. According to O’Neil  
et al. [1] tree nut consumers comprised a lower 
percentage (p < 0.0001) of the population below the 
estimated average requirement (EAR) for vitamins A, 
E, and C, folate, calcium, iron, magnesium, and zinc 
and thus possessed better nutrient adequacy than non-
consumers.  
Tree nuts are considered as an excellent energy 
source. With triacylglycerols being the predominate 
component, the lipid contents in tree nuts vary from 
53.5% in almonds to 75.1% in pine nuts [2]. Nuts are 
generally low in available carbohydrate and glycemic 
index, ranging from 27.5 g/100 g in pistachios to 12.3 
g/100 g in Brazil nuts.  
Tree nuts are characterized by a high content of 
protein [3]. Most tree nuts proteins are rich in arginine. 
This amino acid can be metabolized by endothelial NO  
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synthase to nitric oxide, an important signaling 
molecule and a potent vasodilator [4]. A ratio of lysine 
to arginine in nut proteins generally is lower than that of 
animal proteins. This ratio is associated with a 
significantly lower risk of developing hypercholestero- 
lemia and atherosclerosis, which also decreases the 
risk of cardiovascular diseases [4]. 
To the most commercially-important tree nuts 
belong: 
• almonds (Prunus dulcis, Rosaceae),  
• Brazil nuts (Bertholletia excelsa, Lecythisaceae), 
• cashew (Anacardium occidentale, 
Anacardiaceae),  
• hazelnuts (Corylus avellana L., Betulaceae),  
• macadamia nuts (Macadamia interfolia, 
Proteaceae),  
• pecans (Carya illinoinensis, Juglandaceae),  
• pine nuts (Pinus spp., Pineaceae),  
• pistachios (Pistacia vera L., Anacardiaceae),  
• walnuts (Julans regia, Juglandaceae). 
The aim of this article is to review the role of tree 
nuts in prevention of cardiovascular disease 
1. TREE NUTS AS A SOURCE OF MONO- AND 
POLYUNSATURATED FAATTY ACIDS 
The lipids of tree nuts are generally high in 
unsaturated fats, with the exception being Brazil and 
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cashew nut oils (Table 1). Although tree nut oils 
differed considerably in their levels of individual fatty 
acids, oleic acid (C18:1 ω-9) and linoleic acid (C18:2 
ω-6) are considered as the two predominant ones. The 
oleic/linoleic (O/L) ratio is greatest in hazelnuts, while 
the lowest ratios were reported for pine nut and walnut 
oils. Of particular note is that walnuts are the only tree 
nut containing a significant amount of α-linolenic acid 
(C18:3 ω-3). 
There is epidemiological evidence that dietary 
monounsaturated fatty acids (MUFAs) have a 
beneficial effect on the risk of CHD. Moreover, 
evidence from controlled clinical studies has shown 
that MUFAs favorably affect a number of risk factors for 
CHD, including plasma lipids and lipoproteins, and in 
vitro LDL oxidative susceptibility [11]. MUFAs may 
decrease platelet aggregation, increase bleeding time, 
and increase fibrinolysis, thereby protecting against 
thrombogenesis [12-14]. 
Several observational and experimental studies 
show the beneficial effects of omega-3 poly-
unsaturated fatty acids (PUFAs) in cardiovascular 
disease. The results from such studies justify 
supplementation of omega-3 PUFA in primary and 
secondary prevention of several clinical conditions, 
including coronary heart disease, sudden cardiac death 
and heart failure. [15, 16]. Omega-3 PUFAs may 
protect against CVD through several mechanisms: 
acting as an antiatherogenic agent, lowering serum 
triacylglicerols, lowering blood pressure, improving 
endothelial function, reducing inflammation, inhibiting 
platelet aggregation and thrombosis, and decreasing 
the incidence of arrhythmias [17-19]. 
2. TREE NUTS AS A SOURCE OF PHYTOSTEROLS 
According to literature data, beta-sitosterol is the 
most abundant sterol in all tree nut types, followed by 
stigmasterol and campesterol (Table 2). Phytosterols 
reduce cholesterol absorption from the gut, due to their 
structural similarity with cholesterol (Figure 1). In the 
last decades, purified plant sterols or stanols have 
been added to various foods items to obtain functional 
foods with remarkable hypocholesterolemic activity. A 
Table 1: Content of Unsaturated Fatty Acids in Edible Tree Nuts Lipid (g/100 g oil) [5-10] 
Nut type C16:1 ω7 C18:1 ω9 C20:1 ω9 C18:2 ω6 C18:3 ω3 
Almond 0.40-0.43 65.70-67.62 - 24.03-24.80 trace 
Brazil nut  0.29 29.76-38.36 - 36.84-45.17 0.074 
Cashew 0.34 56.87-60.57 0.19 17.03-22.22 0.21 
Hazelnut 0.16-0.19 79.57-79.64 0.15-0.16 11.78-12.72 0.08 
Macadamia 17.95-20.8 54.1-60.08 2.62-2.53 2.32-3.74 - 
Pecan - 62.36 - 27.69 1.25 
Pine nut 0.08 24.82-27.67 1.32-1.38 45.02-46.41 19.28 
Pistachio 1.07 55.11-56.75 - 28.56-29.45 0.33-0.37 
Walnut 0.07 14.80-16.96 0.19 58.64-63.10 11.67-13.43 
 
Table 2: Content of the Main Phytosterols in Edible Tree Nuts Lipid (mg/100 g oil) [5, 8, 9, 20, 21] 
Nut Type Campesterol Stigmasterol β-Sitosterol Δ5-Avenasterol 
Almond 5.50-10.6 5.17-6.59 207-322 43.9 
Brazil nut 1.75 8.02 91.4 32.1 
Cashew 19.3 1.57 250 16.7 
Hazelnut 10.1-11.4 1.85-2.43 155-203 6.16-12.2 
Macadamia 7.33-12.3 3.83 151-197 20.8 
Pecan 8.20 3.28 167 10.0 
Pine nut 32.1 2.75 198 66.2 
Pistachio 10.8 1.9 219.6 22.2 
Walnut 7.76-8.28 0.60-1.34 143-154 8.60-13.7 
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daily intake of plant sterols or stanols of 1.6-2g/day is 
able to reduce cholesterol absorption from the gut by 
about 30%, and plasma LDL cholesterol levels by 8-
10%. Since the action of plant sterols or stanols on 
plasma LDL cholesterol is additive to that of statins, the 
former can be used to increase the latter's 
hypocholesterolemic action in patients needing a mark- 
ed reduction in plasma LDL cholesterol levels [22-24].  
 
Figure 1: Chemical structure of beta-sitosterol and 
cholesterol. 
3. TREE NUTS AS A SOURCE OF NATURAL 
ANTIOXIDANTS 
The LDL oxidation plays a key role in atherogenesis 
[25]. In this way modified LDLs are the pathogenesis of 
atherosclerotic lesions via the formation of foam cells. 
Oxidized LDLs have been detected in atherosclerotic 
vessels. They can decrease the bioactivity of nitrogen 
oxide in endothelial cells, which causes dilation in 
response to increased blood flow. A large number of 
epidemiological, case-control, and prospective or 
prospective cohort studies on the link of dietary 
antioxidant intake to the reduction/prevention of 
cardiovascular diseases exist. The impact of 
antioxidants pertaining to LDL oxidation, which plays 
an important role in the early atherogenic process, has 
been confirmed in several studies. 
In tree nuts a role of natural antioxidants play 
tocopherols (lipophilic compounds, Figure 2) and 
polyphenols (lipophobic compounds, Figure 3). 
 
Figure 2: Chemical structure of tocopherols. 
 
Figure 3: Chemical structure of natural phenolic antioxidants present in tree nuts. 
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The tocopherol contents of major nut types are 
summarized in Table 3. Four tocopherol isomers were 
reported in all tree nuts at various levels. The 
predominant tocopherol isomer in tree nut oils is γ-
tocopherol, with the exception being almond and 
hazelnut lipids, which are high in α-tocopherol. The 
levels of both the α- and γ-isomers are similar in pine 
nut oil. Worth to be emphasized is information, that one 
of γ-CEHC, the metabolite of γ-tocopherol [2,7,8-
trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman (γ-
CEHC)]) may have an anti-inflammatory effect as 
demonstrated by its down-regulating capacity of 
cycloxygenase-2 and 5-lipoxygenase [27-29 ].  
The antioxidant properties of tree nut polyphenols 
were confirmed in vitro studies using several chemical 
methods (Table 4). The same properties were also 
observed in vivo studies. In human studies 
consumption of hazelnuts (1 g/day/kg body weight) 
improved oxidative stress markers [36]. The research 
of Hudthagosol et al. [37] (a randomized, placebo-
controlled, crossover trial) with pecan consumption 
indicated that the bioactive constituents from pecan are 
absorbable and contribute to the postprandial 
antioxidant defenses in the human body.  
Table 3: Content of Tocopherols in Edible Tree Nuts (g/100 g Nutmeat, Fresh Weight) According to USDA National 
Nutrient Database for Standard Reference [26] 
Nut type α-Tocopherol β-Tocopherol γ-Tocopherol δ-Tocopherol 
Almond 25.63 0.23 0.64 0.07 
Brazil nut 5.65 0.01 9.56 0.63 
Cashew 0.90 0.03 5.31 0.36 
Hazelnut 15.03 0.33  0.00 0.00 
Macadamia 0.54 0.00 0.00 0.00 
Pecan 1.40 0.39 24.44 0.47 
Pine nut 9.33 0.00 11.15 0.00 
Pistachio 12.30 0.00 11.15 0.00 
Walnut 12.30 0.00 22.0 0.80 
 
Table 4: Antioxidant Potential of the Tree Nuts Confirmed in vitro Studies 
Nut Type Conclusions Reference 
Almond 
 
 
Peanut, 
hazelnut, almond 
 
Almond 
 
 
 
 
 
Hazelnut 
 
 
 
Walnut 
 
Almond 
Extracts prepared from whole almond seeds and their brown skins showed antioxidant activity evaluated 
using a cooked comminuted pork model, a β-carotene-linoleate model, and a bulk stripped-corn oil system. 
RP-HPLC analysis revealed the presence of caffeic, ferulic, p-coumaric, and sinapic acids as the major 
phenolic acids in the extracts examined. 
Roasted skins obtained from the industrial processing of peanuts, hazelnuts, and almonds as well as 
fractions containing low- and high-molecular-weight bioactives exhibited high total antioxidant capacity, 
ORACFL, antiradical activity against DPPH radical, and reducing power. 
Phenolic compounds present in a crude extract of almonds and its fractions, after separation on a lipophilic 
Sephadex LH-20 column, showed antioxidant and antiradical properties, as revealed following studies 
using a β-carotene-linoleate model system, the total antioxidant activity method, DPPH radical-scavenging 
assay, and reducing power evaluation. Results of these assays showed the highest values of antioxidant 
activity for the tannins fraction. RP-HPLC analysis of a crude extract from almond seeds revealed the 
presence of vanillic, caffeic, p-coumaric, and ferulic acids (after basic hydrolysis), as well as quercetin, 
kaempferol, and isorhamnetin (after acidic hydrolysis), delphinidin and cyanidin (after n-butanol-HCl 
hydrolysis), and procyanidin B2 and B3. 
The antioxidant activity of a crude hazelnut extract and its fractions was confirmed by the ABTS radical 
cation and DPPH radical-scavenging assays, reducing power, and β-carotene-linoleate model system. In 
the extract, five phenolic acids, namely gallic acid, caffeic acid, p-coumaric acid, ferulic acid, and sinapic 
acid, were tentatively identified and quantified, among which gallic acid was the most abundant in both free 
and esterified forms. 
Copper-mediated LDL oxidation was inhibited by 84% in the presence of a walnut extract. Plasma TBARS 
formation was significantly inhibited by the walnut extracts. 
Almond-pellicle flavonoids increased the resistance of copper-mediated LDL oxidation in vitro and ex vitro 
and acted synergistically with vitamins C and E. 
[30] 
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4. NUTS CONSUMPTION AND CORONARY HEART 
AND CARDIOVASCULAR DISEASE 
Results of numerous investigations suggested that 
nut consumption might reduce the risk of coronary 
heart and cardiovascular disease. by improving serum 
blood lipids [38, 39]. Subjects who consumed tree nuts 
more than four times per week experienced 
substantially fewer definite fatal CHD events and 
definite nonfatal myocardial infarctions, when 
compared with those who consumed nuts less than 
once per week [40]. Substitution of energy from 
carbohydrates by the fat from one ounce was is 
associated with a 30% reduction in CHD risk [41].  
In a prospective cohort study, the inverse 
association between nut consumption and the risk of 
CVD mortality among all subjects was observed [42]. In 
a randomized cross-over clinical trial almond 
consumption favorably altered the serum fatty acid by 
increasing total MUFA content. These changes in the 
fatty acid profile are likely associated with lowered CHD 
risk [43]. Supplementation of diet of 20 mildly 
hypercholesterolemic subjects with baru almonds (20 
g/day) reduced total cholesterol by 2.4%, LDL-
cholesterol by 9.2%TC, and HDL-cholesterol by 8.4% 
[44]. Brazil nuts intake improved the lipid profile and 
microvascular function in obese adolescents [45].  
The hazelnut-enrich diet after 12 week significantly 
improved flow-mediated dilation (FMD) in 21 
hypercholesterolemic adults participated in a double 
control sandwich model intervention [46]. In experiment 
of Li et al. [47] increased nut consumption was 
significantly associated with lower LDL cholesterol, 
non-HDL cholesterol, total cholesterol, and 
apolipoprotein-B-100 concentrations. Serum triacylg- 
lycerol concentration was reduced by 24% during 
three-week addition of peanuts to the diet of fifteen 
normolipidemic adults participated in a crossover 
intervention [48]. Two servings/day of a pistachio diet, 
decreased total cholesterol, LDL cholesterol, non-HDL 
cholesterol, and plasma of stearoyl-CoA desaturase 
activity [49]. The diet containing whole pecans 
prevented hyperleptinemia and decreased the content 
of total cholesterol in blood. Addition of pecan oils to 
the diet with reduced the level of triacylglycerol in blood 
[50]. The regular consumption for 5 weeks of walnut-
enriched meat decreasd total cholesterol in blood of by 
12.8%. and increased concentration of gamma-
tocopherol (16.8%) [51]. In overweight adults with 
visceral adiposity consumption of 56 g of walnuts per 
day improved endothelial function [52]. The Adventist 
Health Study found that the greater the consumption of 
nuts (more than five times a week) decreased the risk 
fatal heart attack in track six years [53]. 
The study of Nishi et al. [43] revealed that almond 
consumption altered the serum fatty acids by 
increasing their total MUFA content. These changes in 
the fatty acid profile were postulated as being 
associated with a lower CHD risk. 
In the etiology and development of atherosclerosis 
plaque important role play a chronic inflammation. The 
activation of the vascular endothelium is an early 
inflammatory event in the development of 
atherosclerosis loading to endothelium dysfunction and 
its consequences [54]. The bioactive compounds 
present in nuts (ω-3 polyunsaturated fatty acids, dietary 
fiber, magnesium, L-arginine, and some antioxidants) 
can protect human against inflammation [55]. 
According to Jiang et al. [56] frequent nut and 
consumption is associated with lower levels of 
inflammatory markers.  
CONCLUSIONS 
In summary, well-designed human intervention 
studies are steel needed to further validate the health 
effects of various nuts. Some limitations from previous 
studies need to be addressed to demonstrate more 
results about activity of individual bioactive compounds 
of nuts. It has been suggested that future human 
studies should address subject characteristics, their 
health status, and other confounding factors before 
making any reliable conclusions for the health effects of 
nuts. 
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